Showing 1 to 10 of 2296 records(fetched in 1.302 seconds)
TitleGlobal Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action.
AuthorsOhannessian, R; Duong, TA; Odone, A
JournalJMIR public health and surveillance
Publication Date2 Apr 2020
Date Added to PubMed3 Apr 2020
AbstractOn March 11, 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) outbreak as a pandemic, with over 720,000 cases reported in more than 203 countries as of 31 March. The response strategy included early diagnosis, patient isolation, symptomatic monitoring of contacts as well as suspected and confirmed cases, and public health quarantine. In this context, telemedicine, particularly video consultations, has been promoted and scaled up to reduce the risk of transmission, especially in the United Kingdom and the United States of America. Based on a literature review, the first conceptual framework for telemedicine implementation during outbreaks was published in 2015. An updated framework for telemedicine in the COVID-19 pandemic has been defined. This framework could be applied at a large scale to improve the national public health response. Most countries, however, lack a regulatory framework to authorize, integrate, and reimburse telemedicine services, including in emergency and outbreak situations. In this context, Italy does not include telemedicine in the essential levels of care granted to all citizens within the National Health Service, while France authorized, reimbursed, and actively promoted the use of telemedicine. Several challenges remain for the global use and integration of telemedicine into the public health response to COVID-19 and future outbreaks. All stakeholders are encouraged to address the challenges and collaborate to promote the safe and evidence-based use of telemedicine during the current pandemic and future outbreaks. For countries without integrated telemedicine in their national health care system, the COVID-19 pandemic is a call to adopt the necessary regulatory frameworks for supporting wide adoption of telemedicine.
Linkhttp://doi.org/10.2196/18810
TitleTelemedicine and the 2019 coronavirus (SARS-CoV-2).
AuthorsSossai, P; Uguccioni, S; Casagrande, S
JournalInternational journal of clinical practice
Publication Date1 Oct 2020
Date Added to PubMed21 Jun 2020
AbstractIn 2020 during the CoronaVirus Disease19 (COVID19) pandemic caused by da SARS-CoV-2, the weakness of e-health (electronic health) (ie the lack of direct contact between physician and patient) may prove to be a strength, given the high contagiousness and relative lethality of the virus. In Italy the lack of preparation for supporting the patient load (shortage of personal protection devices, shortage of Intensive Care Unit) beds in comparison with other European Countries, and the poor early diagnostic and therapeutic activity has led us to suggest a project that uses an online platform between General Practitioners and patients in order to reduce moving infected individuals and to perform the diagnosis and treatment early on.
Linkhttp://doi.org/10.1111/ijcp.13592
Title[Telemedicine in the fight against SARS-COV-2-opportunities and possible applications in otorhinolaryngology : Narrative review].
AuthorsHagge, D; Knopf, A; Hofauer, B
JournalHNO
Publication Date1 Jun 2020
Date Added to PubMed18 Apr 2020
AbstractThe COVID-19 pandemic is bringing healthcare systems worldwide to the brink of collapse. One reason for this is the rapidly increasing number of new infections. On the other hand, the high sickness rates of doctors and nurses, particularly in ENT medicine, are aggravating the situation. Telemedicine can be a useful tool to reduce the number of physician-patient contacts. This could break infection chains and minimize the risk of infection for physicians. To prepare the review, a selective literature search was conducted at www.pubmed.com using the relevant English technical terms for telemedicine and ENT. In addition, research was conducted at www.news.google.com on current developments of the COVID-19 pandemic with the search terms "telemedicine" and "COVID-19." Telemedicine can be helpful in direct contact with patients as well as in the conciliar support of general practitioners. The available studies show that, on average, more than 50% of medical consultations could be carried out telemedically. Both physicians and patients rate the use of telemedicine positively. Neither image quality nor the handling of the technology are relevant obstacles to a reliable diagnosis. Patients indicated that the telemedical consultation did not last longer than a traditional consultation. Patients also highlighted the faster and better availability of medical care through telemedicine. Telemedicine can make a decisive contribution to coping with the current COVID-19 pandemic. Furthermore, the establishment of telemedicine can help us to become better prepared for future pandemics.
Linkhttp://doi.org/10.1007/s00106-020-00864-7
TitleOcular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): Interest of telemedicine during the pandemic context.
AuthorsDaruich, A; Martin, D; Bremond-Gignac, D
JournalJournal francais d'ophtalmologie
Publication Date1 May 2020
Date Added to PubMed27 Apr 2020
AbstractWe report here the case of a 27-year-old man who consulted by telemedicine during the Coronavirus disease 2019 (COVID-19) pandemic, due to foreign body sensation and left eye redness. Examination revealed unilateral eyelid edema and moderate conjunctival hyperemia. A few hours later, the patient experienced intense headache and developed fever, cough and severe dyspnea. A nasopharyngeal swab proved positive for SARS-CoV-2. This case demonstrates that conjunctivitis can be the inaugural manifestation of the COVID-19 infection. It illustrates the interest of telemedicine in ophthalmology during the COVID-19 pandemic, since moderate conjunctival hyperemia can be the first sign of a severe respiratory distress.
Linkhttp://doi.org/10.1016/j.jfo.2020.04.002
TitleEmergency implementation of telemedicine for epilepsy in Spain: Results of a survey during SARS-CoV-2 pandemic.
AuthorsConde-Blanco, E; Centeno, M; Tio, E; Muriana, D; García-Peñas, JJ; Serrano, P; Nagel, AG; Serratosa, J; Jiménez, ÁP; Toledo, M; Donaire, A; Manzanares, I; Betrán, O; Carreño, M
JournalEpilepsy & behavior : E&B
Publication Date1 Oct 2020
Date Added to PubMed17 Jun 2020
AbstractTeleneurology in Spain had not been implemented so far in clinical practice, except in urgent patients with stroke. Telemedicine was hardly used in epilepsy, and patients and neurologists usually preferred onsite visits. Our goal was to study impressions of adult and pediatric epileptologists about the use of telemedicine after emergent implementation during the new coronavirus 2019 (COVID-19) pandemic. An online survey was sent to the members of the Spanish Epilepsy Society and the members of the Epilepsy Study Group of the Catalan Neurological Society, inquiring about different aspects of telemedicine in epilepsy during the pandemic lockdown. A total of 66 neurologists responded, mostly adult neurologists (80.3%), the majority with a monographic epilepsy clinic (4 out of 5). Of all respondents, 59.1% reported to attend more than 20 patients with epilepsy (PWE) a week. During the pandemic, respondents handled their epilepsy clinics mainly with telephone calls (88%); only 4.5% used videoconference. Changes in antiseizure medications were performed less frequently than during onsite visits by 66.6% of the epileptologists. Scales were not administered during these visits, and certain types of information such as sudden expected unrelated death in epilepsy (SUDEP) were felt to be more appropriate to discuss in person. More than 4 out of 5 of the neurologists (84.8%) stated that they would be open to perform some telematic visits in the future. In Spain, emergent implantation of teleneurology has shown to be appropriate for the care of many PWE. Technical improvements, extended use of videoconference and patient selection may improve results and patient and physician satisfaction.
Linkhttp://doi.org/10.1016/j.yebeh.2020.107211
TitleTelemedicine in neurosurgery during the novel coronavirus (COVID-19) pandemic.
AuthorsSzmuda, T; Ali, S; Słoniewski, P; Group, NW
JournalNeurologia i neurochirurgia polska
Publication Date1 Dec 2020
Date Added to PubMed23 Apr 2020
Abstract
Linkhttp://doi.org/10.5603/PJNNS.a2020.0038
TitleTelemedicine During COVID-19 and Beyond: A Practical Guide and Best Practices Multidisciplinary Approach for the Orthopedic and Neurologic Pain Physical Examination.
AuthorsWahezi, SE; Duarte, RV; Yerra, S; Thomas, MA; Pujar, B; Sehgal, N; Argoff, C; Manchikanti, L; Gonzalez, D; Jain, R; Kim, CH; Hossack, M; Senthelal, S; Jain, A; Leo, N; Shaparin, N; Wong, D; Wong, A; Nguyen, K; Singh, JR; Grieco, G; Patel, A; Kinon, MD; Kaye, AD
JournalPain physician
Publication Date1 Aug 2020
Date Added to PubMed19 Sep 2020
AbstractThe COVID pandemic has impacted almost every aspect of human interaction, causing global changes in financial, health care, and social environments for the foreseeable future. More than 1.3 million of the 4 million cases of COVID-19 confirmed globally as of May 2020 have been identified in the United States, testing the capacity and resilience of our hospitals and health care workers. The impacts of the ongoing pandemic, caused by a novel strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have far-reaching implications for the future of our health care system and how we deliver routine care to patients. The adoption of social distancing during this pandemic has demonstrated efficacy in controlling the spread of this virus and has been the only proven means of infection control thus far. Social distancing has prompted hospital closures and the reduction of all non-COVID clinical visits, causing widespread financial despair to many outpatient centers. However, the need to treat patients for non-COVID problems remains important despite this pandemic, as care must continue to be delivered to patients despite their ability or desire to report to outpatient centers for their general care. Our national health care system has realized this need and has incentivized providers to adopt distance-based care in the form of telemedicine and video medicine visits. Many institutions have since incorporated these into their practices without financial penalty because of Medicare's 1135 waiver, which currently reimburses telemedicine at the same rate as evaluation and management codes (E/M Codes). Although the financial burden has been alleviated by this policy, the practitioner remains accountable for providing proper assessment with this new modality of health care delivery. This is a challenge for most physicians, so our team of national experts has created a reference guide for musculoskeletal and neurologic examination selection to retrofit into the telemedicine experience. To describe and illustrate musculoskeletal and neurologic examination techniques that can be used effectively in telemedicine. Consensus-based multispecialty guidelines. Tertiary care center. Literature review of the neck, shoulder, elbow, wrist, hand, lumbar, hip, and knee physical examinations were performed. A multidisciplinary team comprised of physical medicine and rehabilitation, orthopedics, rheumatology, neurology, and anesthesia experts evaluated each examination and provided consensus opinion to select the examinations most appropriate for telemedicine evaluation. The team also provided consensus opinion on how to modify some examinations to incorporate into a nonhealth care office setting. Sixty-nine examinations were selected by the consensus team. Household objects were identified that modified standard and validated examinations, which could facilitate the examinations.The consensus review team did not believe that the modified tests altered the validity of the standardized tests. Examinations selected are not validated for telemedicine. Qualitative and quantitative analyses were not performed. The physical examination is an essential component for sound clinical judgment and patient care planning. The physical examinations described in this manuscript provide a comprehensive framework for the musculoskeletal and neurologic examination, which has been vetted by a committee of national experts for incorporation into the telemedicine evaluation.
Link
TitleTelemedicine in the Era of Coronavirus Disease 2019 (COVID-19): A Neurosurgical Perspective.
AuthorsBlue, R; Yang, AI; Zhou, C; De Ravin, E; Teng, CW; Arguelles, GR; Huang, V; Wathen, C; Miranda, SP; Marcotte, P; Malhotra, NR; Welch, WC; Lee, JYK
JournalWorld neurosurgery
Publication Date1 Jul 2020
Date Added to PubMed20 May 2020
AbstractDespite the substantial growth of telemedicine and the evidence of its advantages, the use of telemedicine in neurosurgery has been limited. Barriers have included medicolegal issues surrounding provider reimbursement, interstate licensure, and malpractice liability as well as technological challenges. Recently, the coronavirus disease 2019 (COVID-19) pandemic has limited typical evaluation of patients with neurologic issues and resulted in a surge in demand for virtual medical visits. Meanwhile, federal and state governments took action to facilitate the rapid implementation of telehealth programs, placing a temporary lift on medicolegal barriers that had previously limited its expansion. This created a unique opportunity for widespread telehealth use to meet the surge in demand for remote medical care. After initial hurdles and challenges, our experience with telemedicine in neurosurgery at Penn Medicine has been overall positive from both the provider and the patients' perspective. One of the unique challenges we face is guiding patients to appropriately set up devices in a way that enables an effective neuroexamination. However, we argue that an accurate and comprehensive neurologic examination can be conducted through a telemedicine platform, despite minor weaknesses inherent to absence of physical presence. In addition, certain neurosurgical visits such as postoperative checks, vascular pathology, and brain tumors inherently lend themselves to easier evaluation through telehealth visits. In the era of COVID-19 and beyond, telemedicine remains a promising and effective approach to continue neurologic patient care.
Linkhttp://doi.org/10.1016/j.wneu.2020.05.066
TitleTelemedicine in the face of the COVID-19 pandemic.
AuthorsVidal-Alaball, J; Acosta-Roja, R; Pastor Hernández, N; Sanchez Luque, U; Morrison, D; Narejos Pérez, S; Perez-Llano, J; Salvador Vèrges, A; López Seguí, F
JournalAtencion primaria
Publication Date1 Dec
Date Added to PubMed14 May 2020
AbstractThe novel coronavirus SARS-CoV-2 is a positive single-stranded RNA virus that can be immediately translated and integrated into the host cell with its own RNA messenger, facilitating replication inside the cell and infectivity. The rapid progression of the disease presents a real challenge for the whole world. As the usual capacity for citizen care is exceeded, health professionals and governments struggle. One of the most important strategies to reduce and mitigate the advance of the epidemic are social distance measures; this is where telemedicine can help, and provide support to the healthcare systems, especially in the areas of public health, prevention and clinical practices, just as it is doing in others sectors. Telemedicine connects the convenience, low cost, and ready accessibility of health-related information and communication using the Internet and associated technologies. Telemedicine during the coronavirus epidemic has been the doctors' first line of defense to slow the spread of the coronavirus, keeping social distancing and providing services by phone or videoconferencing for mild to focus personal care and limited supplies to the most urgent cases.
Linkhttp://doi.org/10.1016/j.aprim.2020.04.003
TitleRates of Symptomatic SARS-CoV-2 Infection in Patients With Autoimmune Liver Diseases in Northern Italy: A Telemedicine Study.
AuthorsRigamonti, C; Cittone, MG; De Benedittis, C; Rizzi, E; Casciaro, GF; Bellan, M; Sainaghi, PP; Pirisi, M
JournalClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Publication Date1 Sep 2020
Date Added to PubMed2 Jun 2020
AbstractSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus responsible for a variety of clinical manifestations that, besides the lungs, can involve several other organs, leading to both mild and severe complications.1-3.
Linkhttp://doi.org/10.1016/j.cgh.2020.05.047
MNCHFPRHHIV/AIDSMalariaNoncommunicable diseaseCOVID-19Decision-makingEducation & trainingBehavior changeGovernancePrivacy & securityEquityCHWsYouth & adolescentsSystematic reviewsProtocols & research designMedical RecordsLaboratoryPharmacyHuman ResourcesmHealthSMSChatbotsAI